TOTALENERGIES 72.210 € (-1,15 %)
SOITEC 124.700 € (-3,07 %)
KERING 264.900 € (-0,17 %)
ROBERTET 812.000 € (-1,46 %)
SHELL PLC 35.110 € (-1,10 %)
AEGON 7.468 € (-0,27 %)
ENGIE 26.960 € (+0,22 %)
BASIC-FIT 31.800 € (-0,81 %)
EIFFAGE 130.250 € (+0,70 %)
AYVENS 11.900 € (-1,41 %)
EUTELSAT COMMUNIC. 2.554 € (-1,39 %)
WOLTERS KLUWER 59.800 € (-0,23 %)
LEGRAND 145.000 € (+4,54 %)
FLOW TRADERS 25.940 € (+0,39 %)
ABIVAX 88.300 € (+5,69 %)
ESSILORLUXOTTICA 174.750 € (-4,79 %)
ATOS 36.400 € (-0,66 %)
ASML HOLDING 1 656.400 € (+4,10 %)
BOIRON 27.500 € (-0,72 %)
AXA 42.530 € (+0,43 %)
ADYEN 888.300 € (-0,22 %)
THX PHARMA 3.720 € (-5,58 %)
AKZO NOBEL 59.000 € (+0,68 %)
GETLINK SE 18.570 € (+0,05 %)
VINCI 130.300 € (+0,85 %)
UMG 18.630 € (+2,93 %)
FUGRO 11.350 € (+2,44 %)
APERAM 48.980 € (-2,33 %)
SMCP 5.145 € (-0,19 %)
NEXITY 7.800 € (+0,71 %)
SAFRAN 324.000 € (0,00 %)
PERNOD RICARD 62.520 € (-1,39 %)
MEDINCELL 24.640 € (-12,06 %)
MICHELIN 33.320 € (-1,24 %)
TIKEHAU CAPITAL 17.640 € (-1,89 %)
SANOFI 74.880 € (-1,03 %)
2CRSI 44.600 € (-2,58 %)
STMICROELECTRONICS 65.160 € (-0,79 %)
CBI 0.109 € (+6,86 %)
RELX 28.360 € (+0,93 %)
S.E.B. 53.100 € (-2,75 %)
LVMH 511.000 € (-1,79 %)
DASSAULT SYSTEMES 17.315 € (-0,29 %)
ASM INTERNATIONAL 1 046.000 € (+5,89 %)
GL EVENTS 32.950 € (-0,90 %)
AMG 36.700 € (+2,86 %)
CHRISTIAN DIOR 474.400 € (-1,33 %)
GECINA 73.500 € (-1,01 %)
X-FAB 9.580 € (-2,15 %)
AHOLD DEL 35.390 € (-2,26 %)
AIRBUS 187.020 € (+0,93 %)
STELLANTIS NV 5.781 € (-3,21 %)
MEDIANTECHNOLOGIES 5.240 € (+2,75 %)
ACCOR 48.150 € (-0,72 %)
PLUXEE 11.380 € (+1,34 %)
CROSSJECT 1.896 € (-0,11 %)
ALTAREA 96.800 € (+0,31 %)
L'OREAL 382.150 € (-1,04 %)
INPOST 15.310 € (-0,07 %)
LHYFE 2.000 € (-0,99 %) |
17/06/2026 21:40
Tinnitus Quest Builds Momentum with Oxford Research Study, New Funding Call, and Second Tinnitus HackathonEQS-News: Tinnitus Quest / Key word(s): Miscellaneous OXFORD, England, June 17, 2026 /PRNewswire/ -- Tinnitus Quest, an international patient-driven nonprofit dedicated to accelerating research into treatments to silence tinnitus, today announced the launch of a new round of research funding aimed at uncovering bold, innovative ideas to silence tinnitus. The funding call builds on the momentum generated by Tinnitus Quest's first awarded grant, a $230,000 study at the University of Oxford exploring whether transcranial ultrasound stimulation (TUS) can reduce tinnitus by targeting deep brain regions involved in generating the phantom sound. Led by Professor Robin Cleveland, Director of the Institute of Biomedical Engineering at Oxford, the project is investigating whether transcranial ultrasound stimulation (TUS) can modulate neural circuits associated with tinnitus, and which brain targets and stimulation patterns are most effective in reducing tinnitus loudness. Deep brain stimulation has shown promising tinnitus reductions but requires invasive neurosurgery. The Oxford study, if successful, would offer a non-invasive alternative that is safer and more scalable. As part of its new funding round, Tinnitus Quest is seeking even more out-of-the-box ideas for developing effective tinnitus treatments and is also offering a hyperacusis grant on behalf of Hyperacusis Research Ltd. Particularly encouraged is drug and device repurposing; adapting existing treatments could substantially reduce development costs and shorten the path to market. Legendary singer and actress Barbra Streisand said: "Tinnitus Quest gives hope to people who are affected. They are driving research forward and raising much needed awareness, which is why I am happy to support their mission and research." The Barbra Streisand Foundation donated $10,000 last year to help advance the work of Tinnitus Quest. Tinnitus affects hundreds of millions of people worldwide and can cause severe sleep disturbance, anxiety, and reduced quality of life, yet effective treatments remain limited. "In a field that remains severely underfunded, our first grant demonstrated that promising ideas exist. Now we want to uncover a pipeline of even more innovative approaches that could bring us closer to silencing tinnitus," said Hazel Goedhart, co-founder of Tinnitus Quest. Tinnitus Quest also announced that it will host the second edition of its Tinnitus Hackathon on 27–29 October in Dallas, Texas, bringing together leading researchers, patient advocates, and industry representatives for two days of intensive discussions aimed at producing actionable plans to accelerate progress in tinnitus research over the coming 2-3 years. About Tinnitus Quest Tinnitus Quest is a 501(c)(3) nonprofit organization, led by patients and researchers, dedicated to funding 'high risk, high gain' science needed to silence tinnitus. We are building a movement that drives research forward and brings hope to millions of people affected. Learn more and join the 'quiet revolution' at https://tinnitusquest.com/ Contact Information For media inquiries or further information, please contact: Hazel Goedhart, Executive Board Member, media@tinnitusquest.com, +1 (350) 200-0300.
![]() 17.06.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. 2348538 17.06.2026 CET/CEST Source : Webdisclosure.com |
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière


